Breaking News Instant updates and real-time market news.

MUR

Murphy Oil

$14.66 /

+0.69 (+4.94%)

06:37
08/06/20
08/06
06:37
08/06/20
06:37

Murphy Oil reports Q2 adjusted EPS (71c), consensus (94c)

Reports Q2 revenue $285.75M, consensus $395.43M. Produced 168 MBOEPD, including 58% or 98K barrels of oil per day. Improved average lease operating expenses by 22% from 1Q20 to less than $9 per barrel of oil equivalent in Q2, or approximately $7 per barrel of oil equivalent excluding workover expenses. "Q2 was difficult not only for our industry, but also our company. As we endured the economic fallout from the global pandemic and the unprecedented oil price collapse, we made the decision to shut in wells, primarily at a single offshore facility. Absent these shut-ins, our assets performed very well and production volumes would have been essentially flat with Q1. I am proud of our team's ability to manage uptime and performance despite the unique challenges presented by recent events," stated CEO Roger Jenkins.

  • 06

    Aug

MUR Murphy Oil
$14.66 /

+0.69 (+4.94%)

08/04/20 Credit Suisse
Murphy Oil assumed with a Neutral at Credit Suisse
07/15/20 Wolfe Research
Murphy Oil downgraded to Underperform from Peer Perform at Wolfe Research
06/22/20 Goldman Sachs
Murphy Oil downgraded to Neutral from Buy at Goldman Sachs
06/19/20 Mizuho
Murphy Oil upgraded to Neutral from Underperform at Mizuho

TODAY'S FREE FLY STORIES

General news
FX Update: The dollar has softened » 07:30
09/28/20
09/28
07:30
09/28/20
07:30

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Unusual put flow in option market yesterday » 07:30
09/28/20
09/28
07:30
09/28/20
07:30
WB

Weibo

$32.53 /

-2.015 (-5.83%)

Notable put activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WB Weibo
$32.53 /

-2.015 (-5.83%)

08/06/20 OTR Global
Weibo view upgraded to Mixed from Negative at OTR Global
07/07/20 Citi
New Wave could offer a 'bit more' for Sina, says Citi
05/20/20 HSBC
Weibo price target lowered to $34.50 from $38 at HSBC
05/06/20 OTR Global
Weibo downgraded to Negative from Mixed at OTR Global
WB Weibo
$32.53 /

-2.015 (-5.83%)

WB Weibo
$32.53 /

-2.015 (-5.83%)

WB Weibo
$32.53 /

-2.015 (-5.83%)

WB Weibo
$32.53 /

-2.015 (-5.83%)

Hot Stocks
Oragenics trading halted, news pending  07:26
09/28/20
09/28
07:26
09/28/20
07:26
OGEN

Oragenics

$0.63 /

+0.0242 (+3.97%)

 
ShowHide Related Items >><<
OGEN Oragenics
$0.63 /

+0.0242 (+3.97%)

OGEN Oragenics
$0.63 /

+0.0242 (+3.97%)

04/16/20 H.C. Wainwright
Oragenics downgraded to Neutral from Buy at H.C. Wainwright
Recommendations
Stryker price target raised to $232 from $222 at Wells Fargo » 07:24
09/28/20
09/28
07:24
09/28/20
07:24
SYK

Stryker

$205.00 /

+5.63 (+2.82%)

, WMGI

Wright Medical

$30.45 /

+0.02 (+0.07%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYK Stryker
$205.00 /

+5.63 (+2.82%)

WMGI Wright Medical
$30.45 /

+0.02 (+0.07%)

SYK Stryker
$205.00 /

+5.63 (+2.82%)

09/11/20 Wolfe Research
Stryker initiated with a Peer Perform at Wolfe Research
07/31/20 Citi
Stryker price target raised to $232 from $227 at Citi
05/26/20 Piper Sandler
Piper Sandler positive on Merit Medical's Starboard agreement on board members
05/01/20 Deutsche Bank
Stryker price target lowered to $228 from $243 at Deutsche Bank
WMGI Wright Medical
$30.45 /

+0.02 (+0.07%)

08/26/20 Stifel
Wright Medical downgraded to Hold from Buy at Stifel
03/13/20 Needham
Needham downgrades Wright Medical, sees higher bid as unlikely in current market
03/13/20 Needham
Wright Medical downgraded to Hold from Buy at Needham
01/07/20 Piper Sandler
Stryker downgraded to Neutral from Overweight at Piper Sandler
SYK Stryker
$205.00 /

+5.63 (+2.82%)

SYK Stryker
$205.00 /

+5.63 (+2.82%)

WMGI Wright Medical
$30.45 /

+0.02 (+0.07%)

SYK Stryker
$205.00 /

+5.63 (+2.82%)

Recommendations
Alkermes management 'clearly bullish' on ALKS 4230, says Mizuho » 07:23
09/28/20
09/28
07:23
09/28/20
07:23
ALKS

Alkermes

$16.74 /

+0.17 (+1.03%)

After hosting a series of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$16.74 /

+0.17 (+1.03%)

ALKS Alkermes
$16.74 /

+0.17 (+1.03%)

08/21/20 Mizuho
Alkermes comments on FDA panel may pressure shares, says Mizuho
07/30/20 Mizuho
Alkermes price target raised to $19 from $16 at Mizuho
07/30/20 Goldman Sachs
Alkermes downgraded to Sell from Neutral at Goldman Sachs
06/19/20 Piper Sandler
Biogen price target lowered to $260 from $307 at Piper Sandler
ALKS Alkermes
$16.74 /

+0.17 (+1.03%)

Recommendations
Darden price target raised to $115 from $90 at Loop Capital » 07:22
09/28/20
09/28
07:22
09/28/20
07:22
DRI

Darden

$97.23 /

-0.21 (-0.22%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$97.23 /

-0.21 (-0.22%)

DRI Darden
$97.23 /

-0.21 (-0.22%)

09/25/20 MKM Partners
Darden price target raised to $115 from $110 at MKM Partners
09/25/20 BMO Capital
Darden price target raised to $96 from $84 at BMO Capital
09/25/20 Truist
Darden price target raised to $128 from $100 at Truist
09/25/20 Raymond James
Darden price target raised to $115 from $100 at Raymond James
DRI Darden
$97.23 /

-0.21 (-0.22%)

  • 21
    Apr
DRI Darden
$97.23 /

-0.21 (-0.22%)

DRI Darden
$97.23 /

-0.21 (-0.22%)

DRI Darden
$97.23 /

-0.21 (-0.22%)

Upgrade
Merit Medical upgraded to Equal Weight at Wells Fargo » 07:22
09/28/20
09/28
07:22
09/28/20
07:22
MMSI

Merit Medical

$41.37 /

+0.57 (+1.40%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

04:57 Today Wells Fargo
Merit Medical upgraded to Equal Weight from Underweight at Wells Fargo
07/30/20 Barrington
Merit Medical price target raised to $54 from $49 at Barrington
07/30/20 Piper Sandler
Merit Medical price target raised to $55 from $50 at Piper Sandler
05/27/20 Barrington
Merit Medical price target raised to $49 from $42 at Barrington
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

Upgrade
Itron upgraded to Strong Buy from Outperform at Raymond James on valuation » 07:21
09/28/20
09/28
07:21
09/28/20
07:21
ITRI

Itron

$56.24 /

+0.79 (+1.42%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

04:56 Today Raymond James
Itron upgraded to Strong Buy from Outperform at Raymond James
08/25/20 Wolfe Research
Itron initiated with an Underperform at Wolfe Research
08/04/20 Oppenheimer
Itron price target lowered to $75 from $82 at Oppenheimer
06/26/20 Oppenheimer
Itron price target lowered to $82 from $90 at Oppenheimer
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

Recommendations
Alibaba price target raised to $350 from $280 at Loop Capital » 07:18
09/28/20
09/28
07:18
09/28/20
07:18
BABA

Alibaba

$271.14 /

+1.45 (+0.54%)

Loop Capital analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$271.14 /

+1.45 (+0.54%)

BABA Alibaba
$271.14 /

+1.45 (+0.54%)

08/26/20 Argus
Alibaba price target raised to $330 from $260 at Argus
08/24/20 Susquehanna
Alibaba price target raised to $350 from $275 at Susquehanna
08/24/20 Barclays
Alibaba price target raised to $320 from $300 at Barclays
08/21/20 Truist
Alibaba price target raised to $285 from $242 at Truist
BABA Alibaba
$271.14 /

+1.45 (+0.54%)

BABA Alibaba
$271.14 /

+1.45 (+0.54%)

BABA Alibaba
$271.14 /

+1.45 (+0.54%)

BABA Alibaba
$271.14 /

+1.45 (+0.54%)

Recommendations
Mizuho 'incrementally more bullish' on AbbVie integration of Allergan » 07:18
09/28/20
09/28
07:18
09/28/20
07:18
ABBV

AbbVie

$86.20 /

+0.3 (+0.35%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$86.20 /

+0.3 (+0.35%)

ABBV AbbVie
$86.20 /

+0.3 (+0.35%)

09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
ABBV AbbVie
$86.20 /

+0.3 (+0.35%)

ABBV AbbVie
$86.20 /

+0.3 (+0.35%)

ABBV AbbVie
$86.20 /

+0.3 (+0.35%)

Recommendations
Ameriprise price target lowered to $194 from $200 at Credit Suisse » 07:14
09/28/20
09/28
07:14
09/28/20
07:14
AMP

Ameriprise

$146.71 /

+2.1 (+1.45%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

08/13/20 Barclays
Ameriprise initiated with an Overweight at Barclays
06/25/20
Fly Intel: Top five analyst upgrades
06/25/20 Goldman Sachs
Ameriprise upgraded to Buy from Neutral at Goldman Sachs
06/22/20 Credit Suisse
Ameriprise price target raised to $200 from $165 at Credit Suisse
AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

Recommendations
Square price target raised to $175 from $170 at Credit Suisse » 07:13
09/28/20
09/28
07:13
09/28/20
07:13
SQ

Square

$157.84 /

+5.29 (+3.47%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$157.84 /

+5.29 (+3.47%)

SQ Square
$157.84 /

+5.29 (+3.47%)

09/24/20
Fly Intel: Top five analyst upgrades
09/24/20 Oppenheimer
Square upgraded to Outperform upon re-assumption of coverage at Oppenheimer
09/24/20 Oppenheimer
Square upgraded to Outperform from Perform at Oppenheimer
09/24/20 Mizuho
Square's Cash App is 'virtually unstoppable,' says Mizuho
SQ Square
$157.84 /

+5.29 (+3.47%)

SQ Square
$157.84 /

+5.29 (+3.47%)

SQ Square
$157.84 /

+5.29 (+3.47%)

SQ Square
$157.84 /

+5.29 (+3.47%)

Hot Stocks
Silver Bull appoints Christopher Richards as CFO » 07:12
09/28/20
09/28
07:12
09/28/20
07:12
SVBL

Silver Bull

$0.00 /

+ (+0.00%)

Silver Bull Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVBL Silver Bull
$0.00 /

+ (+0.00%)

Hot Stocks
Delta 9 completes final services milestone under Prarie Trichomes agreement » 07:11
09/28/20
09/28
07:11
09/28/20
07:11
VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

DELTA 9 CANNABIS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

05/20/20 Canaccord
Delta 9 Cannabis upgraded to Speculative Buy from Hold at Canaccord
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Medipharm enters Buyout Agreement for 100% ownership of Australia subsidiary » 07:10
09/28/20
09/28
07:10
09/28/20
07:10
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Hot Stocks
Cubic awarded contract from NGA to provide commercial software » 07:09
09/28/20
09/28
07:09
09/28/20
07:09
CUB

Cubic

$58.70 /

+2.485 (+4.42%)

Cubic announced Pixia,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CUB Cubic
$58.70 /

+2.485 (+4.42%)

CUB Cubic
$58.70 /

+2.485 (+4.42%)

09/22/20 Canaccord
Cubic strategy validated by Elliott stake, says Canaccord
09/22/20 RBC Capital
Cubic price target raised to $52 from $48 at RBC Capital
09/21/20 Citi
Elliott's interest in Cubic supportive of underlying value, says Citi
09/16/20 Citi
Cubic price target raised to $60 from $50 at Citi
CUB Cubic
$58.70 /

+2.485 (+4.42%)

CUB Cubic
$58.70 /

+2.485 (+4.42%)

CUB Cubic
$58.70 /

+2.485 (+4.42%)

Earnings
Perceptron reports Q4 EPS (15c), one est. (15c) » 07:08
09/28/20
09/28
07:08
09/28/20
07:08
PRCP

Perceptron

$4.13 /

-0.04 (-0.96%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRCP Perceptron
$4.13 /

-0.04 (-0.96%)

PRCP Perceptron
$4.13 /

-0.04 (-0.96%)

03/19/20 B. Riley FBR
B. Riley FBR downgrades four names with exposure to auto manufacturers
03/19/20 B. Riley FBR
Perceptron downgraded to Neutral from Buy at B. Riley FBR
PRCP Perceptron
$4.13 /

-0.04 (-0.96%)

PRCP Perceptron
$4.13 /

-0.04 (-0.96%)

Hot Stocks
Avrobio gets orphan drug designation from the EC for AVR-RD-02 » 07:07
09/28/20
09/28
07:07
09/28/20
07:07
AVRO

Avrobio

$13.53 /

+0.37 (+2.81%)

Avrobio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVRO Avrobio
$13.53 /

+0.37 (+2.81%)

AVRO Avrobio
$13.53 /

+0.37 (+2.81%)

03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
03/17/20 Janney Montgomery Scott
Avrobio weakness a buying opportunity, says Janney Montgomery Scott
02/19/20 Nomura Instinet
Avrobio price target raised to $50 from $35 at Nomura Instinet
02/11/20 Mizuho
Avrobio price target raised to $35 from $28 at Mizuho
AVRO Avrobio
$13.53 /

+0.37 (+2.81%)

  • 13
    Feb
Recommendations
Morgan Stanley leans 'more cautious' on Zoom with shares 'priced for perfection' » 07:07
09/28/20
09/28
07:07
09/28/20
07:07
ZM

Zoom Video

$496.38 /

+30.875 (+6.63%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
09/14/20 Baird
Zoom Video still in early innings of market penetration, says Baird
09/03/20 Needham
Crowdstrike price target raised to $170 from $120 at Needham
09/03/20 Stifel
Crowdstrike price target raised to $145 from $125 at Stifel
ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

ZM Zoom Video
$496.38 /

+30.875 (+6.63%)

Hot Stocks
Freeline promotes Romuald Corbau as CSO » 07:07
09/28/20
09/28
07:07
09/28/20
07:07
FRLN

Freeline

$16.40 /

+0.02 (+0.12%)

Freeline Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRLN Freeline
$16.40 /

+0.02 (+0.12%)

FRLN Freeline
$16.40 /

+0.02 (+0.12%)

09/01/20 Evercore ISI
Freeline initiated with an Outperform at Evercore ISI
09/01/20 Wedbush
Wedbush bullish on Freeline, initiates with an Outperform
09/01/20 Wedbush
Freeline initiated with an Outperform at Wedbush
09/01/20 Morgan Stanley
Freeline initiated with an Overweight at Morgan Stanley
  • 07
    Aug
FRLN Freeline
$16.40 /

+0.02 (+0.12%)

Hot Stocks
Devon Energy and WPX Energy to combine in all-stock merger, sees accretion » 07:06
09/28/20
09/28
07:06
09/28/20
07:06
DVN

Devon Energy

$8.81 /

-0.16 (-1.78%)

, WPX

WPX Energy

$4.45 /

+0.03 (+0.68%)

Devon Energy (DVN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

WPX WPX Energy
$4.45 /

+0.03 (+0.68%)

DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/14/20 Northland
Devon Energy initiated with an Outperform at Northland
08/26/20 Capital One
Devon Energy upgraded on robust FCF profile at Capital One
08/26/20 Capital One
Devon Energy upgraded to Overweight from Equalweight at Capital One
WPX WPX Energy
$4.45 /

+0.03 (+0.68%)

09/22/20 Truist
WPX Energy upgraded to Buy from Hold at Truist
09/22/20 Truist
WPX Energy upgraded to Buy from Hold at Truist
09/14/20 Northland
WPX Energy downgraded to Market Perform from Outperform at Northland
07/27/20 Seaport Global
WPX Energy initiated with a Neutral at Seaport Global
DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

WPX WPX Energy
$4.45 /

+0.03 (+0.68%)

DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

WPX WPX Energy
$4.45 /

+0.03 (+0.68%)

DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

DVN Devon Energy
$8.81 /

-0.16 (-1.78%)

WPX WPX Energy
$4.45 /

+0.03 (+0.68%)

Hot Stocks
Quotient announces receipt of FDA EUA for MosaiQ COVID-19 antibody test » 07:06
09/28/20
09/28
07:06
09/28/20
07:06
QTNT

Quotient

$5.14 /

+0.415 (+8.78%)

Quotient announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QTNT Quotient
$5.14 /

+0.415 (+8.78%)

QTNT Quotient
$5.14 /

+0.415 (+8.78%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
QTNT Quotient
$5.14 /

+0.415 (+8.78%)

  • 11
    Sep
  • 07
    Nov
QTNT Quotient
$5.14 /

+0.415 (+8.78%)

Hot Stocks
Clarus' Sierra Bullets to acquire assets of Barnes Bullets for $30.5M » 07:05
09/28/20
09/28
07:05
09/28/20
07:05
CLAR

Clarus

$13.59 /

+0.05 (+0.37%)

Clarus Corporation's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLAR Clarus
$13.59 /

+0.05 (+0.37%)

CLAR Clarus
$13.59 /

+0.05 (+0.37%)

09/18/20 Lake Street
Clarus price target raised to $17 from $15 at Lake Street
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 William Blair
Clarus initiated with an Outperform at William Blair
07/24/20 Roth Capital
Clarus upgraded to Buy from Neutral at Roth Capital
CLAR Clarus
$13.59 /

+0.05 (+0.37%)

Hot Stocks
TTEC Holdings increases semi-annual cash dividend to 40c per share » 07:04
09/28/20
09/28
07:04
09/28/20
07:04
TTEC

TTEC Holdings

$52.24 /

+0.25 (+0.48%)

TTEC Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTEC TTEC Holdings
$52.24 /

+0.25 (+0.48%)

TTEC TTEC Holdings
$52.24 /

+0.25 (+0.48%)

08/10/20
Fly Intel: Top five analyst downgrades
08/10/20 Sidoti
TTEC Holdings downgraded to Neutral from Buy at Sidoti
07/23/20 Morgan Stanley
TTEC Holdings initiated with an Equal Weight at Morgan Stanley
01/17/20
Fly Intel: Top five analyst initiations
TTEC TTEC Holdings
$52.24 /

+0.25 (+0.48%)

  • 06
    Dec
Hot Stocks
Orchard Therapeutics receives EMA PRIME designation for OTL-203 » 07:04
09/28/20
09/28
07:04
09/28/20
07:04
ORTX

Orchard Therapeutics

$4.41 /

-0.165 (-3.61%)

Orchard Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$4.41 /

-0.165 (-3.61%)

ORTX Orchard Therapeutics
$4.41 /

-0.165 (-3.61%)

09/14/20 Oppenheimer
Orchard Therapeutics price target lowered to $16 from $26 at Oppenheimer
09/10/20 SMBC Nikko
Orchard Therapeutics initiated with an Outperform at SMBC Nikko
05/22/20 JPMorgan
Orchard Therapeutics price target lowered to $17 from $26 at JPMorgan
ORTX Orchard Therapeutics
$4.41 /

-0.165 (-3.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.